ECMM Candida IV

Update on Candida IV study at #TIMM2025 Still open for registration 🔬🧫🧪 Join now!

Preliminary results of the Candida IV study at #ISHAM2025 Study is still open to join 🔬🥼👩‍🔬

🧫 Persistent candidemia: lessons from a European cohort In 258 patients from 18 countries, 20% had ≥5 days of (+) cultures → higher mortality (50% vs 32%). Low EQUAL #Candida Scores predicted persistence 💡 Adherence saves lives 🔗 journalofinfection.com/article/S0163-…

⏰Only 70 days left to join the ECMM #CandidaIV study! 🌎 A global, multicenter study on non-albicans Candida infections 🔬 Focus: Resistance, tolerance & clinical outcomes in #candidemia 📅 Enrollment open until September 30, 2025 📥 Register now and be part of it!

Proud to present the progress of @EcmmCandidaIV study at #ISHAM2025 @ISHAM_Mycology @eurconfmedmycol Still open for participation!

Exciting news! The ECMM Candida IV study is now featured on the ECMM website! Find all the details here: ecmm.info/working-groups… ⁦@martinhoenigl⁩ ⁦@Stella_A_I⁩ ⁦@SarahSedik⁩ ecmm.info/working-groups…

🎉 Exciting news from #ESCMIDGlobal2025! Proud to present our ECMM Candida IV study Poster at #ESCMID2025! Great discussions and inspring feedback - thanks to everyone who stopped by! #Candida #ClinicalResearch #ESMID #PosterPresentation #Oraltalk

Join our Global ECMM Candida IV Study 🍄 @eurconfmedmycol @EcmmCandidaIV @martinhoenigl @Stella_A_I #ESCMIDGlobal2025

@bryan_p_white @eurconfmedmycol Hi Bryan, could you please share your email with us via DM so we can provide you with more information? Alternatively, feel free to contact sarah.sedik@medunigraz.at or stella.wolfgruber@medunigraz.at directly

@EcmmCandidaIV @eurconfmedmycol Who do we reach out to get more information?

ECMM Candida IV Study is still open for participation Global study on non-albicans candidemia Requirements: 🔬Clinical data + isolates (no limit per site) 📅Apr 2024-Sep 2025 📦Ship isolates in one batch at study end 💰Case-based reimbursement available @eurconfmedmycol